» Articles » PMID: 39465448

Functional and Oncological Outcomes Following More Than Three Consecutive Surgical Resections for Multiple Relapses of Initially Grade 2 IDH-mutated Gliomas

Overview
Specialty Neurosurgery
Date 2024 Oct 28
PMID 39465448
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Second and third surgeries were demonstrated as safe and efficient in recurrent diffuse low-grade glioma (LGG). Here, the feasibility of more than 3 resections is investigated.

Methods: Patients who underwent 4 or 5 operations for recurrent initially WHO grade 2 IDH-mutated gliomas were consecutively selected.

Results: Twenty-three operations were performed in five patients (all males, mean age 27.2 ± 4 years). Three patients underwent 5 surgeries and two patients underwent 4 surgeries. Twelve procedures (52%) were achieved with awake mapping, including all 4th and 5th operations but one. Repeat electrical mapping detected changes of the cortical maps between at least two awake surgeries in 4 patients. No patients experienced permanent neurological impairment (KPS score ≥ 80 in all cases). The patients returned to work after 22 surgeries among 23 (95.6%). There were 3 oligodendrogliomas and 2 astrocytomas (4 gliomas became malignant at fourth or fifth operation). Although the preoperative tumor volume significantly increased before the fourth (p = 0.026) and fifth operation (p = 0.003) compared with the first operation, there was no significant difference between the residual tumor volume after the fourth or fifth resection versus the first one. The mean delay was 10.6 ± 3.9 years before chemotherapy and 15.4 ± 3.4 years before radiotherapy (one patient never received adjuvant treatment after 21.5 years). The mean follow-up duration was 18.3 ± 3.1 years since the first surgery (2.3 ± 1.8 years since the last surgery). Three patients were still alive at last follow-up.

Conclusions: This is the first series showing that to reoperate beyond three times is feasible with a low functional risk and a long survival in multiple LGG recurrences, with the use of awake mapping in 87.5% of 4th and 5th surgeries.

Citing Articles

The onco-functional balance in diffuse gliomas: Evolution of the concept over the past decade - And the next steps.

Duffau H Brain Spine. 2025; 5():104170.

PMID: 39850593 PMC: 11753966. DOI: 10.1016/j.bas.2024.104170.

References
1.
Alhalabi O, Dao Trong P, Kaes M, Jakobs M, Kessler T, Oehler H . Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk-benefit analysis. J Neurooncol. 2024; 167(2):245-255. PMC: 11023957. DOI: 10.1007/s11060-024-04595-5. View

2.
de Eulate-Beramendi S, Rigau V, Taillandier L, Duffau H . Delayed leptomeningeal and subependymal seeding after multiple surgeries for supratentorial diffuse low-grade gliomas in adults. J Neurosurg. 2013; 120(4):833-9. DOI: 10.3171/2013.10.JNS131512. View

3.
Blonski M, Obara T, Brzenczek C, Pouget C, Dillier C, Meyer M . Initial PCV Chemotherapy Followed by Radiotherapy Is Associated With a Prolonged Response But Late Neurotoxicity in 20 Diffuse Low-Grade Glioma Patients. Front Oncol. 2022; 12:827897. PMC: 8931287. DOI: 10.3389/fonc.2022.827897. View

4.
Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard J, Bauchet L . Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article. J Neurosurg. 2013; 118(6):1157-68. DOI: 10.3171/2013.1.JNS121. View

5.
Capo G, Skrap M, Guarracino I, Isola M, Battistella C, Ius T . Cognitive Functions in Repeated Glioma Surgery. Cancers (Basel). 2020; 12(5). PMC: 7281009. DOI: 10.3390/cancers12051077. View